[1]
Brais, C. et al. 2017. Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation. Journal of Pharmacy & Pharmaceutical Sciences. 20, (Jan. 2017), 8–14. DOI:https://doi.org/10.18433/J30W4F.